|
Acorda Therapeutics (, ) is a biotechnology company based in Hawthorne, New York. Acorda Therapeutics develops drugs to improve therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system.[1] Acorda manufactures and markets the drugs Zanaflex and Ampyra in the United States.
History Corporate governance the members of the board of directors of Acorda Therapeutics are:[2] Ron Cohen, Barry Greene, John Kelley, Sandra Panem, Lorin J. Randall, Steven M. Rauscher, Ian F. Smith, and Wise Young. Products Products on the market Products under development References External links Hoover's
|
Encyclopedia
top
